Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,284,676
-$4,720,738 QoQ
Shares Held
615,976
-37.7% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. ERAS ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,284,676 | 615,976 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,005,414 | 989,210 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,014,628 | 810,385 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $585,697 | 268,670 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $773,863 | 609,343 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $792,183 | 578,238 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,894,389 | 754,738 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,383,671 | 873,141 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,065,156 | 1,722,525 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,355,940 | 658,225 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,473,560 | 691,814 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,474,848 | 748,655 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,827,989 | 1,024,635 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,397,765 | 464,375 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,519,293 | 352,505 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,603,170 | 205,535 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,079,574 | 193,820 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $248,151 | 28,855 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $446,223 | 28,641 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $70,110 | 3,304 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||